Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

52.53 +1.42 (+2.78%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
News headline image
5 Monster Stocks to Hold for the Next 10 Years ↗
These companies are just starting to realize the potential in up-and-coming fields, like AI and gene editing. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy? ↗
Via The Motley Fool
News headline image
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years ↗
Via The Motley Fool
News headline image
CRSPR Stock Could Be Ready to Deliver on Its Massive Promise
CRSPR Therapeutics has ambitious goals for its gene editing technology and may be getting ready to generate the revenue needed to deliver for shareholders 
Via MarketBeat
News headline image
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics? ↗
Via The Motley Fool
News headline image
2 Biotech Stocks That Are Screaming Buys in May ↗
Via The Motley Fool
News headline image
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire? ↗
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline. 
Via The Motley Fool
News headline image
3 Monster Stocks to Hold for the Next 10 Years ↗
The planets are lining up for these three stocks' underlying companies. 
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
In a rising market, the iconic growth investor is adding to positions trading well below their earlier highs. 
Via The Motley Fool
Topics Artificial Intelligence World Trade
News headline image
CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst ↗
CRISPR reports data showing dose-dependent lipid reduction and strong safety, with plans to present full results in late 2025. 
Via Benzinga
News headline image
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns. 
Via Benzinga
News headline image
These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results ↗
 
Via Benzinga
News headline image
Lumentum Holdings To Rally Around 46%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks ↗
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
News headline image
Cathie Wood Sells Palantir Shares Worth $2.65 Million Ahead Of Earnings, Doubles Down On This Chip Giant ↗
On Wednesday, April 30, 2025, Cathie Wood sold $2.65 million worth of Palantir shares through various ARK ETFs. 
Via Benzinga
News headline image
2 Beaten-Down Stocks With Incredible Upside Potential ↗
Via The Motley Fool
News headline image
5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years ↗
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
3 Magnificent Stocks That Could Double or More by 2030 ↗
Via The Motley Fool
News headline image
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗
Via The Motley Fool
News headline image
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street ↗
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The iconic growth investor made some interesting moves during Friday's market pullback. 
Via The Motley Fool
News headline image
Cathie Wood's Ark Invest Loads Up On Amazon, Coinbase: Offloads UiPath, Roblox ↗
 
Via Benzinga
News headline image
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March ↗
Via The Motley Fool
Topics Bankruptcy Economy World Trade
News headline image
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today ↗
Via The Motley Fool
Topics Government World Trade
News headline image
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns ↗
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies. 
Via Investor's Business Daily
News headline image
The Future of Healthcare: 10 Predictions For The Next Decade
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
2 Beaten-Down Stocks to Buy on the Dip ↗
Via The Motley Fool
News headline image
2 No-Brainer Biotech Stocks to Buy Right Now ↗
Via The Motley Fool
News headline image
Cathie Wood Stands By Tesla's $2,600 Price Target Despite 40% Stock Drop: 'It's Winner Take Most ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Continues To Load Up On Tempus AI, Dumps Bitcoin-Focused Block In Tech Meltdown Aftermath ↗
On Tuesday, Cathie Wood‘s Ark Invest executed notable trades, including significant activity involving Tempus AI Inc. (NASDAQ:TEM), Block Inc. (NYSE:XYZ), and DraftKings Inc.< 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback